September 9, 2024 by King’s College London A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help breathlessness in patients with respiratory disease—and may cause side effects. Researchers warn prescribing medicines for a use which it has not been licensed could make things worse, even though the prescriber...
by Emily Head, Imperial College London Credit: Shutterstock Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19. This is according to a new study of 38 people who were previously hospitalized with severe COVID-19. The results, published in Immunity, suggest these patients have an altered landscape of immune cells in their airways...
EUROPEAN SOCIETY OF CARDIOLOGY Sophia-Antipolis, 9 December 2021:A small study has suggested that COVID-19 patients who continue to be short of breath during physical activity one year after recovering from the infection may have suffered heart damage. The research is presented today at EuroEcho 2021, a scientific congress of the European Society of Cardiology (ESC).1...
AMERICAN THORACIC SOCIETY July 27, 2018–Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. IMAGE: CANNABIS NEITHER IMPROVES NOR WORSENS BREATHLESSNESS IN PEOPLE WITH ADVANCED...
